ANXA2_HUMAN - dbPTM
ANXA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ANXA2_HUMAN
UniProt AC P07355
Protein Name Annexin A2
Gene Name ANXA2
Organism Homo sapiens (Human).
Sequence Length 339
Subcellular Localization Secreted, extracellular space, extracellular matrix, basement membrane . Melanosome . In the lamina beneath the plasma membrane. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Translocated from the cytoplasm to the
Protein Description Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9. [PubMed: 18799458]
Protein Sequence MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSTVHEILC
------CCCHHHHHH
38.85-
2O-linked_Glycosylation------MSTVHEILC
------CCCHHHHHH
38.8523301498
2Phosphorylation------MSTVHEILC
------CCCHHHHHH
38.8523401153
3Phosphorylation-----MSTVHEILCK
-----CCCHHHHHHH
25.2830266825
9GlutathionylationSTVHEILCKLSLEGD
CCHHHHHHHHHCCCC
5.2422833525
9S-palmitoylationSTVHEILCKLSLEGD
CCHHHHHHHHHCCCC
5.2429575903
10AcetylationTVHEILCKLSLEGDH
CHHHHHHHHHCCCCC
37.3523954790
10UbiquitinationTVHEILCKLSLEGDH
CHHHHHHHHHCCCCC
37.35-
12PhosphorylationHEILCKLSLEGDHST
HHHHHHHHCCCCCCC
15.1829255136
16PhosphorylationCKLSLEGDHSTPPSA
HHHHCCCCCCCCCHH
24.1624719451
18PhosphorylationLSLEGDHSTPPSAYG
HHCCCCCCCCCHHHC
47.5529255136
19O-linked_GlycosylationSLEGDHSTPPSAYGS
HCCCCCCCCCHHHCC
35.48OGP
19PhosphorylationSLEGDHSTPPSAYGS
HCCCCCCCCCHHHCC
35.4829255136
20PhosphorylationLEGDHSTPPSAYGSV
CCCCCCCCCHHHCCE
24.70-
20 (in isoform 2)Phosphorylation-24.708898866
21PhosphorylationEGDHSTPPSAYGSVK
CCCCCCCCHHHCCEE
31.51-
21 (in isoform 2)Phosphorylation-31.5117081983
22PhosphorylationGDHSTPPSAYGSVKA
CCCCCCCHHHCCEEE
35.0129255136
24PhosphorylationHSTPPSAYGSVKAYT
CCCCCHHHCCEEEEC
17.8029255136
26PhosphorylationTPPSAYGSVKAYTNF
CCCHHHCCEEEECCC
14.0429255136
28AcetylationPSAYGSVKAYTNFDA
CHHHCCEEEECCCCH
37.0626051181
28UbiquitinationPSAYGSVKAYTNFDA
CHHHCCEEEECCCCH
37.0621906983
28 (in isoform 2)Ubiquitination-37.06-
30NitrationAYGSVKAYTNFDAER
HHCCEEEECCCCHHH
9.12-
30PhosphorylationAYGSVKAYTNFDAER
HHCCEEEECCCCHHH
9.1221945579
30 (in isoform 2)Phosphorylation-9.1229743597
31PhosphorylationYGSVKAYTNFDAERD
HCCEEEECCCCHHHH
33.9821945579
36PhosphorylationAYTNFDAERDALNIE
EECCCCHHHHCCCHH
53.6027642862
37PhosphorylationYTNFDAERDALNIET
ECCCCHHHHCCCHHH
35.9027642862
40PhosphorylationFDAERDALNIETAIK
CCHHHHCCCHHHHHH
8.5427642862
42PhosphorylationAERDALNIETAIKTK
HHHHCCCHHHHHHCC
5.3127642862
44PhosphorylationRDALNIETAIKTKGV
HHCCCHHHHHHCCCC
29.8621815630
46 (in isoform 2)Ubiquitination-8.32-
47AcetylationLNIETAIKTKGVDEV
CCHHHHHHCCCCCEE
41.5423236377
47UbiquitinationLNIETAIKTKGVDEV
CCHHHHHHCCCCCEE
41.5421906983
48PhosphorylationNIETAIKTKGVDEVT
CHHHHHHCCCCCEEE
27.2421609022
49AcetylationIETAIKTKGVDEVTI
HHHHHHCCCCCEEEE
52.5121466224
49PhosphorylationIETAIKTKGVDEVTI
HHHHHHCCCCCEEEE
52.5127251275
49SumoylationIETAIKTKGVDEVTI
HHHHHHCCCCCEEEE
52.5125114211
49UbiquitinationIETAIKTKGVDEVTI
HHHHHHCCCCCEEEE
52.5121906983
55PhosphorylationTKGVDEVTIVNILTN
CCCCCEEEEEEEECC
19.7020068231
61PhosphorylationVTIVNILTNRSNAQR
EEEEEEECCCCCHHH
25.4563753367
65 (in isoform 2)Ubiquitination-36.53-
67 (in isoform 2)Ubiquitination-48.06-
75PhosphorylationRQDIAFAYQRRTKKE
HHHHHHHHHHHCHHH
8.9728152594
79PhosphorylationAFAYQRRTKKELASA
HHHHHHHCHHHHHHH
48.9727251275
80MalonylationFAYQRRTKKELASAL
HHHHHHCHHHHHHHH
42.3026320211
81MalonylationAYQRRTKKELASALK
HHHHHCHHHHHHHHH
58.3026320211
81UbiquitinationAYQRRTKKELASALK
HHHHHCHHHHHHHHH
58.30-
85PhosphorylationRTKKELASALKSALS
HCHHHHHHHHHHHHC
46.9230266825
88UbiquitinationKELASALKSALSGHL
HHHHHHHHHHHCCCH
33.14-
89PhosphorylationELASALKSALSGHLE
HHHHHHHHHHCCCHH
34.9834801879
92PhosphorylationSALKSALSGHLETVI
HHHHHHHCCCHHHHH
24.7128450419
93PhosphorylationALKSALSGHLETVIL
HHHHHHCCCHHHHHH
30.19-
97PhosphorylationALSGHLETVILGLLK
HHCCCHHHHHHHHHC
21.1428450419
99 (in isoform 2)Ubiquitination-3.09-
103PhosphorylationETVILGLLKTPAQYD
HHHHHHHHCCHHHCC
5.7227251275
104AcetylationTVILGLLKTPAQYDA
HHHHHHHCCHHHCCH
58.4623954790
104UbiquitinationTVILGLLKTPAQYDA
HHHHHHHCCHHHCCH
58.4621906983
105PhosphorylationVILGLLKTPAQYDAS
HHHHHHCCHHHCCHH
24.6721815630
109PhosphorylationLLKTPAQYDASELKA
HHCCHHHCCHHHHHH
18.6423927012
110PhosphorylationLKTPAQYDASELKAS
HCCHHHCCHHHHHHH
31.3827251275
112PhosphorylationTPAQYDASELKASMK
CHHHCCHHHHHHHHC
40.3322199227
115AcetylationQYDASELKASMKGLG
HCCHHHHHHHHCCCC
34.0723954790
115UbiquitinationQYDASELKASMKGLG
HCCHHHHHHHHCCCC
34.0721906983
117PhosphorylationDASELKASMKGLGTD
CHHHHHHHHCCCCCC
21.3123927012
118SulfoxidationASELKASMKGLGTDE
HHHHHHHHCCCCCCH
4.8228183972
119AcetylationSELKASMKGLGTDED
HHHHHHHCCCCCCHH
48.7926051181
119MalonylationSELKASMKGLGTDED
HHHHHHHCCCCCCHH
48.7926320211
119SuccinylationSELKASMKGLGTDED
HHHHHHHCCCCCCHH
48.7923954790
119UbiquitinationSELKASMKGLGTDED
HHHHHHHCCCCCCHH
48.79-
122AcetylationKASMKGLGTDEDSLI
HHHHCCCCCCHHHHH
39.5319608861
122UbiquitinationKASMKGLGTDEDSLI
HHHHCCCCCCHHHHH
39.5319608861
122 (in isoform 2)Ubiquitination-39.53-
123PhosphorylationASMKGLGTDEDSLIE
HHHCCCCCCHHHHHH
41.0623927012
127PhosphorylationGLGTDEDSLIEIICS
CCCCCHHHHHHHHHH
29.2420201521
130PhosphorylationTDEDSLIEIICSRTN
CCHHHHHHHHHHCCH
31.4327251275
133S-nitrosocysteineDSLIEIICSRTNQEL
HHHHHHHHHCCHHHH
2.50-
133AcetylationDSLIEIICSRTNQEL
HHHHHHHHHCCHHHH
2.5019608861
133GlutathionylationDSLIEIICSRTNQEL
HHHHHHHHHCCHHHH
2.5022833525
133S-nitrosylationDSLIEIICSRTNQEL
HHHHHHHHHCCHHHH
2.5022178444
133S-palmitoylationDSLIEIICSRTNQEL
HHHHHHHHHCCHHHH
2.5029575903
133 (in isoform 2)Ubiquitination-2.50-
134PhosphorylationSLIEIICSRTNQELQ
HHHHHHHHCCHHHHH
31.5646164657
136PhosphorylationIEIICSRTNQELQEI
HHHHHHCCHHHHHHH
25.5920873877
137 (in isoform 2)Ubiquitination-32.02-
141PhosphorylationSRTNQELQEINRVYK
HCCHHHHHHHHHHHH
49.09-
145PhosphorylationQELQEINRVYKEMYK
HHHHHHHHHHHHHHC
38.5127251275
147PhosphorylationLQEINRVYKEMYKTD
HHHHHHHHHHHHCCH
9.6720068231
148AcetylationQEINRVYKEMYKTDL
HHHHHHHHHHHCCHH
32.9025825284
148MalonylationQEINRVYKEMYKTDL
HHHHHHHHHHHCCHH
32.9026320211
148UbiquitinationQEINRVYKEMYKTDL
HHHHHHHHHHHCCHH
32.9019608861
148 (in isoform 1)Ubiquitination-32.9021890473
151S-nitrosocysteineNRVYKEMYKTDLEKD
HHHHHHHHCCHHHHH
16.30-
151PhosphorylationNRVYKEMYKTDLEKD
HHHHHHHHCCHHHHH
16.3030622161
152AcetylationRVYKEMYKTDLEKDI
HHHHHHHCCHHHHHH
33.9625825284
152MalonylationRVYKEMYKTDLEKDI
HHHHHHHCCHHHHHH
33.9626320211
152UbiquitinationRVYKEMYKTDLEKDI
HHHHHHHCCHHHHHH
33.9619608861
153O-linked_GlycosylationVYKEMYKTDLEKDII
HHHHHHCCHHHHHHH
28.4723301498
153PhosphorylationVYKEMYKTDLEKDII
HHHHHHCCHHHHHHH
28.4720068231
157AcetylationMYKTDLEKDIISDTS
HHCCHHHHHHHCCCC
62.6223954790
157UbiquitinationMYKTDLEKDIISDTS
HHCCHHHHHHHCCCC
62.6221906983
161PhosphorylationDLEKDIISDTSGDFR
HHHHHHHCCCCHHHH
34.8630266825
163PhosphorylationEKDIISDTSGDFRKL
HHHHHCCCCHHHHHH
28.0230266825
164PhosphorylationKDIISDTSGDFRKLM
HHHHCCCCHHHHHHH
41.1630266825
165PhosphorylationDIISDTSGDFRKLMV
HHHCCCCHHHHHHHH
39.92-
166AcetylationIISDTSGDFRKLMVA
HHCCCCHHHHHHHHH
39.6919608861
166UbiquitinationIISDTSGDFRKLMVA
HHCCCCHHHHHHHHH
39.6921890473
166 (in isoform 2)Ubiquitination-39.6921890473
169MalonylationDTSGDFRKLMVALAK
CCCHHHHHHHHHHHC
40.7126320211
169MethylationDTSGDFRKLMVALAK
CCCHHHHHHHHHHHC
40.71-
169UbiquitinationDTSGDFRKLMVALAK
CCCHHHHHHHHHHHC
40.71-
170AcetylationTSGDFRKLMVALAKG
CCHHHHHHHHHHHCC
2.6619608861
170UbiquitinationTSGDFRKLMVALAKG
CCHHHHHHHHHHHCC
2.6619608861
170 (in isoform 2)Ubiquitination-2.66-
171PhosphorylationSGDFRKLMVALAKGR
CHHHHHHHHHHHCCC
1.53-
171SulfoxidationSGDFRKLMVALAKGR
CHHHHHHHHHHHCCC
1.5330846556
175AcetylationRKLMVALAKGRRAED
HHHHHHHHCCCCCCC
11.5219608861
175UbiquitinationRKLMVALAKGRRAED
HHHHHHHHCCCCCCC
11.5219608861
175 (in isoform 2)Ubiquitination-11.52-
176AcetylationKLMVALAKGRRAEDG
HHHHHHHCCCCCCCC
54.5223236377
176MalonylationKLMVALAKGRRAEDG
HHHHHHHCCCCCCCC
54.5226320211
176SuccinylationKLMVALAKGRRAEDG
HHHHHHHCCCCCCCC
54.5223954790
176UbiquitinationKLMVALAKGRRAEDG
HHHHHHHCCCCCCCC
54.52-
179PhosphorylationVALAKGRRAEDGSVI
HHHHCCCCCCCCCCC
51.5027251275
182PhosphorylationAKGRRAEDGSVIDYE
HCCCCCCCCCCCCCE
54.4027251275
184PhosphorylationGRRAEDGSVIDYELI
CCCCCCCCCCCCEEC
28.3730266825
187 (in isoform 2)Ubiquitination-28.79-
188PhosphorylationEDGSVIDYELIDQDA
CCCCCCCCEECCCCH
11.0823927012
194 (in isoform 2)Ubiquitination-39.56-
199PhosphorylationDQDARDLYDAGVKRK
CCCHHHHHHHCCCCC
14.1827273156
202PhosphorylationARDLYDAGVKRKGTD
HHHHHHHCCCCCCCC
23.6827251275
204AcetylationDLYDAGVKRKGTDVP
HHHHHCCCCCCCCCC
47.6926051181
204UbiquitinationDLYDAGVKRKGTDVP
HHHHHCCCCCCCCCC
47.6921906983
206PhosphorylationYDAGVKRKGTDVPKW
HHHCCCCCCCCCCHH
61.5227642862
212AcetylationRKGTDVPKWISIMTE
CCCCCCCHHHHHHCC
57.9423954790
212UbiquitinationRKGTDVPKWISIMTE
CCCCCCCHHHHHHCC
57.9421906983
215PhosphorylationTDVPKWISIMTERSV
CCCCHHHHHHCCCCC
12.759403753
217PhosphorylationVPKWISIMTERSVPH
CCHHHHHHCCCCCHH
2.25-
217SulfoxidationVPKWISIMTERSVPH
CCHHHHHHCCCCCHH
2.2530846556
218PhosphorylationPKWISIMTERSVPHL
CHHHHHHCCCCCHHH
26.9582570423
221PhosphorylationISIMTERSVPHLQKV
HHHHCCCCCHHHHHH
33.4930266825
222 (in isoform 2)Ubiquitination-4.30-
227AcetylationRSVPHLQKVFDRYKS
CCCHHHHHHHHHHHC
51.7523954790
227MethylationRSVPHLQKVFDRYKS
CCCHHHHHHHHHHHC
51.7519608861
227SuccinylationRSVPHLQKVFDRYKS
CCCHHHHHHHHHHHC
51.7523954790
227UbiquitinationRSVPHLQKVFDRYKS
CCCHHHHHHHHHHHC
51.7519608861
227 (in isoform 1)Ubiquitination-51.7521890473
230 (in isoform 2)Ubiquitination-56.86-
232PhosphorylationLQKVFDRYKSYSPYD
HHHHHHHHHCCCHHH
13.2123312004
233AcetylationQKVFDRYKSYSPYDM
HHHHHHHHCCCHHHH
43.7625825284
233MalonylationQKVFDRYKSYSPYDM
HHHHHHHHCCCHHHH
43.7626320211
233PhosphorylationQKVFDRYKSYSPYDM
HHHHHHHHCCCHHHH
43.7627251275
233UbiquitinationQKVFDRYKSYSPYDM
HHHHHHHHCCCHHHH
43.76-
234PhosphorylationKVFDRYKSYSPYDML
HHHHHHHCCCHHHHH
23.1621945579
235PhosphorylationVFDRYKSYSPYDMLE
HHHHHHCCCHHHHHH
14.9821945579
236PhosphorylationFDRYKSYSPYDMLES
HHHHHCCCHHHHHHH
24.8721945579
238NitrationRYKSYSPYDMLESIR
HHHCCCHHHHHHHHH
14.19-
238PhosphorylationRYKSYSPYDMLESIR
HHHCCCHHHHHHHHH
14.1921945579
239PhosphorylationYKSYSPYDMLESIRK
HHCCCHHHHHHHHHH
38.2827251275
240SulfoxidationKSYSPYDMLESIRKE
HCCCHHHHHHHHHHH
3.5430846556
243PhosphorylationSPYDMLESIRKEVKG
CHHHHHHHHHHHHCC
24.5921945579
245AcetylationYDMLESIRKEVKGDL
HHHHHHHHHHHCCHH
38.0619608861
245UbiquitinationYDMLESIRKEVKGDL
HHHHHHHHHHHCCHH
38.0621890473
245 (in isoform 2)Ubiquitination-38.0621890473
246UbiquitinationDMLESIRKEVKGDLE
HHHHHHHHHHCCHHH
66.25-
249UbiquitinationESIRKEVKGDLENAF
HHHHHHHCCHHHHHH
48.04-
251 (in isoform 2)Ubiquitination-45.12-
252PhosphorylationRKEVKGDLENAFLNL
HHHHCCHHHHHHHHH
8.1327251275
253PhosphorylationKEVKGDLENAFLNLV
HHHCCHHHHHHHHHH
51.7817389395
256PhosphorylationKGDLENAFLNLVQCI
CCHHHHHHHHHHHHH
7.5827642862
262GlutathionylationAFLNLVQCIQNKPLY
HHHHHHHHHHCCCCH
2.4214668336
262S-nitrosylationAFLNLVQCIQNKPLY
HHHHHHHHHHCCCCH
2.4225040305
266AcetylationLVQCIQNKPLYFADR
HHHHHHCCCCHHHHH
21.7421466224
266SumoylationLVQCIQNKPLYFADR
HHHHHHCCCCHHHHH
21.74-
266UbiquitinationLVQCIQNKPLYFADR
HHHHHHCCCCHHHHH
21.7421906983
269PhosphorylationCIQNKPLYFADRLYD
HHHCCCCHHHHHHHH
12.78310709061
275PhosphorylationLYFADRLYDSMKGKG
CHHHHHHHHHHCCCC
13.5819534553
277PhosphorylationFADRLYDSMKGKGTR
HHHHHHHHHCCCCCC
14.6123312004
279AcetylationDRLYDSMKGKGTRDK
HHHHHHHCCCCCCCH
62.5119608861
279MalonylationDRLYDSMKGKGTRDK
HHHHHHHCCCCCCCH
62.5126320211
279UbiquitinationDRLYDSMKGKGTRDK
HHHHHHHCCCCCCCH
62.5119608861
281UbiquitinationLYDSMKGKGTRDKVL
HHHHHCCCCCCCHHH
52.14-
296PhosphorylationIRIMVSRSEVDMLKI
EEEEECHHHHCHHHH
34.1721712546
297AcetylationRIMVSRSEVDMLKIR
EEEECHHHHCHHHHH
41.2319608861
297 (in isoform 2)Ubiquitination-41.23-
299 (in isoform 2)Ubiquitination-32.42-
302AcetylationRSEVDMLKIRSEFKR
HHHHCHHHHHHHHHH
29.4523954790
302UbiquitinationRSEVDMLKIRSEFKR
HHHHCHHHHHHHHHH
29.4521906983
305PhosphorylationVDMLKIRSEFKRKYG
HCHHHHHHHHHHHHC
51.3523312004
310AcetylationIRSEFKRKYGKSLYY
HHHHHHHHHCCCCEE
59.9725825284
310MalonylationIRSEFKRKYGKSLYY
HHHHHHHHHCCCCEE
59.9726320211
313AcetylationEFKRKYGKSLYYYIQ
HHHHHHCCCCEEEEE
33.9123954790
313MalonylationEFKRKYGKSLYYYIQ
HHHHHHCCCCEEEEE
33.9126320211
313MethylationEFKRKYGKSLYYYIQ
HHHHHHCCCCEEEEE
33.9119608861
313UbiquitinationEFKRKYGKSLYYYIQ
HHHHHHCCCCEEEEE
33.9119608861
313 (in isoform 1)Ubiquitination-33.9121890473
314PhosphorylationFKRKYGKSLYYYIQQ
HHHHHCCCCEEEEEC
19.7630804295
316PhosphorylationRKYGKSLYYYIQQDT
HHHCCCCEEEEECCC
11.0021082442
317PhosphorylationKYGKSLYYYIQQDTK
HHCCCCEEEEECCCC
10.2127273156
318PhosphorylationYGKSLYYYIQQDTKG
HCCCCEEEEECCCCC
4.4321082442
320AcetylationKSLYYYIQQDTKGDY
CCCEEEEECCCCCCH
20.9819608861
320UbiquitinationKSLYYYIQQDTKGDY
CCCEEEEECCCCCCH
20.9819608861
320 (in isoform 2)Ubiquitination-20.98-
323PhosphorylationYYYIQQDTKGDYQKA
EEEEECCCCCCHHHH
32.3728152594
324AcetylationYYIQQDTKGDYQKAL
EEEECCCCCCHHHHH
59.0623954790
324SumoylationYYIQQDTKGDYQKAL
EEEECCCCCCHHHHH
59.06-
324UbiquitinationYYIQQDTKGDYQKAL
EEEECCCCCCHHHHH
59.062190698
327PhosphorylationQQDTKGDYQKALLYL
ECCCCCCHHHHHHHH
22.1528152594
329AcetylationDTKGDYQKALLYLCG
CCCCCHHHHHHHHCC
34.4726051181
329UbiquitinationDTKGDYQKALLYLCG
CCCCCHHHHHHHHCC
34.47-
331AcetylationKGDYQKALLYLCGGD
CCCHHHHHHHHCCCC
4.1019608861
331UbiquitinationKGDYQKALLYLCGGD
CCCHHHHHHHHCCCC
4.1021890473
331 (in isoform 2)Ubiquitination-4.1021890473
332PhosphorylationGDYQKALLYLCGGDD
CCHHHHHHHHCCCCC
3.5227251275
333PhosphorylationDYQKALLYLCGGDD-
CHHHHHHHHCCCCC-
10.7828152594
334PhosphorylationYQKALLYLCGGDD--
HHHHHHHHCCCCC--
1.9027642862
335GlutathionylationQKALLYLCGGDD---
HHHHHHHCCCCC---
3.4614668336
335PhosphorylationQKALLYLCGGDD---
HHHHHHHCCCCC---
3.4627642862
335S-palmitoylationQKALLYLCGGDD---
HHHHHHHCCCCC---
3.4629575903
336PhosphorylationKALLYLCGGDD----
HHHHHHCCCCC----
39.7127642862
342 (in isoform 2)Ubiquitination--
347 (in isoform 2)Ubiquitination--
351Phosphorylation-------------------
-------------------
27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
12SPhosphorylationKinasePRKCAP17252
GPS
24YPhosphorylationKinaseIGF1RP08069
PSP
24YPhosphorylationKinaseSRCP12931
Uniprot
24YPhosphorylationKinaseSRC64-PhosphoELM
26SPhosphorylationKinasePKCAP04409
PSP
26SPhosphorylationKinasePRKCAP17252
GPS
26SPhosphorylationKinasePKCAP05696
PSP
26SPhosphorylationKinasePRKCBP05771
GPS
26SPhosphorylationKinasePKC-FAMILY-GPS
26SPhosphorylationKinasePKC-Uniprot
26SPhosphorylationKinasePKC_GROUP-PhosphoELM
-KUbiquitinationE3 ubiquitin ligaseCBLL1Q75N03
PMID:31952268

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ANXA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ANXA2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CATB_HUMANCTSBphysical
10777578
TPA_HUMANPLATphysical
12468550
APOH_HUMANAPOHphysical
10809787
S10AA_HUMANS100A10physical
18434302
STAT6_HUMANSTAT6physical
20121258
GAG_HV1H2gagphysical
16501079
A4_HUMANAPPphysical
21832049
RACK1_HUMANGNB2L1physical
22939629
RS13_HUMANRPS13physical
22939629
RL11_HUMANRPL11physical
22939629
MLH1_HUMANMLH1physical
20706999
HMGA1_HUMANHMGA1physical
18850631
DNJC8_HUMANDNAJC8physical
22863883
PA24A_HUMANPLA2G4Aphysical
14599294
S10AA_HUMANS100A10physical
26186194
ANX13_HUMANANXA13physical
26186194
EWS_HUMANEWSR1physical
26344197
PCBP2_HUMANPCBP2physical
26344197
PDCD6_HUMANPDCD6physical
26344197
PA24A_HUMANPLA2G4Aphysical
18065419
S10AA_HUMANS100A10physical
18065419
S10AA_HUMANS100A10physical
28514442
ANX13_HUMANANXA13physical
28514442
AHNK2_HUMANAHNAK2physical
28514442
KLH42_HUMANKLHL42physical
28514442
STAT3_HUMANSTAT3physical
23691485

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00031Tenecteplase
Regulatory Network of ANXA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-104; LYS-115; LYS-148;LYS-152; LYS-157; LYS-227; LYS-279; LYS-302 AND LYS-313, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY.
"The protein-tyrosine kinase substrate p36 is also a substrate forprotein kinase C in vitro and in vivo.";
Gould K.L., Woodgett J.R., Isacke C.M., Hunter T.;
Mol. Cell. Biol. 6:2738-2744(1986).
Cited for: PHOSPHORYLATION AT SER-26.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24; TYR-30; TYR-188 ANDTYR-238, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24; TYR-30; TYR-188;TYR-199; TYR-238; TYR-316; TYR-317 AND TYR-318, AND MASS SPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-30, AND MASSSPECTROMETRY.
"An annexin 2 phosphorylation switch mediates p11-dependenttranslocation of annexin 2 to the cell surface.";
Deora A.B., Kreitzer G., Jacovina A.T., Hajjar K.A.;
J. Biol. Chem. 279:43411-43418(2004).
Cited for: PHOSPHORYLATION AT TYR-24, AND MUTAGENESIS OF TYR-24.

TOP